AbbVie launces HCV resource website with national patient data

AbbVie announced a new interactive online resource, MappingHepC.com, that features national and state-level data on hepatitis C screening, diagnosis and treatment, according to a press release.

“Until now, the HCV patient landscape has been poorly understood, with out-of-date data sources and under-reporting of HCV infections,” Sammy Saab, MD, from the University of California in Los Angeles, said in the release. “The availability of this epidemiology data provides a clearer picture of where the most concentrated populations of people with HCV are located, which is a crucial step towards eliminating the virus in the U.S.”

To address the need for more accurate HCV patient landscape data, AbbVie analyzed two large national laboratory datasets. The datasets included more than 17 million HCV antibody tests and 1.5 million HCV RNA tests performed in U.S. patients between 2013 and 2016.

Findings from the analysis showed that while there was an increase in young adults who were antibody positive between 2013 and 2016, overall rates HCV screening have improved and the rates of baby boomers who are antibody positive have declined.

“We are excited to provide the HCV community with up-to-date information on the evolving HCV landscape,” Vipan Sood, vice president of health economics and outcomes research at AbbVie. “The accessibility of this data will allow stakeholders to focus resources and expertise to their specific communities and to come together to maximize our efforts.”

Reference: www.abbvie.com